Williams Cancer Institute

The World Leaders in Cancer Care, changing the way cancer is treated.

[Williams Cancer Institute @WmsCInstitute]

Cannabis and cancer: what does science really say? 🧬
Some cannabis products may help relieve symptoms like pain, nausea, anxiety, or sleep issues. However, there is currently no solid clinical evidence showing cannabis can cure cancer.
Always speak with your medical team before combining cannabis with cancer treatment. https://t.co/vxTbQjUUMn

[Williams Cancer Institute @WmsCInstitute]

What if your tumor could help your body fight cancer?
At Williams Cancer Institute, we take a different approach to cancer care by targeting the tumor directly. Through advanced image-guided procedures, Pulsed Electric Field (PEF) ablation, and intratumoral immunotherapy, our goal is to help activate the immune system against cancer.
This personalized strategy is designed to stimulate an immune response that may go beyond the treatment site — turning the tumor into a potential source of immune activation.
A different approach. A personalized plan. A new way to think about cancer treatment.
Visit https://t.co/rigWO3TuSX

[Williams Cancer Institute @WmsCInstitute]

🔴 LIVE: Daraxonrasib, GLP-1s, and Cancer https://t.co/PuCVNuaycU

[Williams Cancer Institute @WmsCInstitute]

Can a Blood Thinner Reveal a New Cancer Weakness?

Warfarin is being studied for its potential role in making cancer cells more vulnerable to ferroptosis, a form of cell death linked to oxidative damage.

Read the blog here:
https://t.co/tTFpM5qDSL

[Williams Cancer Institute @WmsCInstitute]

Could GLP-1 medications play a role in the future of cancer care?
In this episode, Dr. Jason Williams and Dr. Charles Goodyear explore emerging research on GLP-1 medications, cancer progression, immunotherapy, AI, and personalized treatment strategies.
Discover how science and innovation may reshape the way we understand and approach cancer treatment.
Watch the full podcast on YouTube.

[Williams Cancer Institute @WmsCInstitute]

Tomorrow on The GoodWill Show — Friday, 1 PM PST

@drgoodyear on two big stories:

🔵Daraxonrasib doubled overall survival in pancreatic cancer at ASCO 2026. Published in NEJM on May 31. What does this mean for the future of chemotherapy?

🔵GLP-1s and the anti-cancer correlation. Ozempic-class drugs are now being linked to lower cancer progression. Real effect, or weight loss in disguise?

Real science. Real implications. Live on X.

[Williams Cancer Institute @WmsCInstitute]

Cancer care is more than treatment.

At Williams Cancer Institute, innovation and personalized care come together to support every patient’s journey with clarity and hope.

Learn more. Link in bio.

[Williams Cancer Institute @WmsCInstitute]

Can nerves influence tumor growth, immunity, and treatment response?

Explore how Cancer Neuroscience is changing our understanding of cancer.
Read the full blog:
 https://t.co/9GECN25Ax9

[Williams Cancer Institute @WmsCInstitute]

We want to let you know that our previous Instagram account was unfortunately closed unexpectedly.
After so much hard work and dedication, we now have to start over from scratch, and today more than ever we would truly appreciate your support
We invite you to follow our new Instagram account and be part of this new chapter with us ✨
Every follow, comment, and share means so much to us.
📲 Instagram: @williamscancerinstitute1
https://t.co/wXoCjB0gdD
Thank you for continuing to support and grow with us

[Williams Cancer Institute @WmsCInstitute]

Advancing cancer care through innovation, research, and personalized treatment strategies.
- Every patient deserves hope.
- International consultations available.

[Jason R. Williams, MD, DABR @jasonwilliamsmd]

In prostate cancer, the moment the needle goes in for a biopsy is the moment you have direct access to the tumor. Standard practice is to take the sample and leave. I see that as a wasted opportunity to start treating right then and there.

[Williams Cancer Institute @WmsCInstitute]

Clinical trials are where better cancer treatments begin.
Before a new therapy becomes part of cancer care, it must be carefully studied for safety, effectiveness, and real patient benefit. Clinical trials help transform scientific ideas into evidence-based treatments.
Learn why they matter in developing safer and more effective cancer therapies: https://t.co/9A5S3X3qJ1

[Williams Cancer Institute @WmsCInstitute]

What if the tumor itself could help activate the immune system?
In this episode, Dr. Jason Williams and Dr. Nathan Goodyear discuss recent research from Williams Cancer Institute on pulsed electric field ablation and intratumoral immunotherapy — an innovative approach designed to treat the tumor directly while engaging the body’s immune response.
Watch the full episode to learn more.
https://t.co/h3Rj2tHtVK

[Williams Cancer Institute @WmsCInstitute]

🔴 LIVE: GLP-1s & Cancer https://t.co/vnhscXZziX

[Williams Cancer Institute @WmsCInstitute]

Read more by @CancerNetwrk https://t.co/b8cgF05RAx

[Williams Cancer Institute @WmsCInstitute]

Oncology has spent decades treating exercise as a footnote to real treatment. @drgoodyear is moving it onto the prescription pad. The body's defense against cancer and against aging runs through the same immune machinery, and movement is one of the few levers that reaches it directly.

[Jason R. Williams, MD, DABR @jasonwilliamsmd]

Chemo destroys the immune system your body needs to clear cancer.

That contradiction has always sat at the center of standard treatment. The drug circulates through every tissue, attacks any cell dividing quickly, and weakens marrow, gut, and follicles along the way. Hair loss is the visible part of a much larger problem.

Intratumoral immunotherapy operates on the opposite principle. It activates the immune response inside the tumor rather than suppressing cells across the body.

[Williams Cancer Institute @WmsCInstitute]

Tomorrow on The GoodWill Show — Friday, 1 PM PST

@drgoodyear and @jasonwilliamsmd break down two stories you've seen the headlines for:
🔵 Ozempic and the cancer conversation. New ASCO 2026 data suggests GLP-1 drugs may slow cancer progression by 31-50%.
🔵 A frog gut microbe that eliminated 100% of tumors in mice with a single dose.

Real science. Real implications. Live on X.